S 
1,396
+3.25%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩68.60bn
FY2016FY2025
Net income
−₩1.60bn
FY2016FY2025
Free cash flow
−₩1.69bn
FY2016FY2025
Shareholders' equity
₩26.78bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩68.60bn | ₩58.59bn | ₩64.78bn | ₩64.35bn | ₩55.30bn | ₩61.57bn | ₩62.15bn | ₩70.76bn | ₩56.48bn | ₩43.90bn |
| Gross profit | ₩13.20bn | ₩11.22bn | ₩13.63bn | ₩13.80bn | ₩8.86bn | ₩12.84bn | ₩12.76bn | ₩13.06bn | ₩11.45bn | ₩9.23bn |
| Operating income | −₩385.0m | −₩1.57bn | ₩660.5m | ₩2.04bn | −₩4.84bn | ₩743.6m | ₩378.5m | ₩2.08bn | ₩904.6m | ₩651.4m |
| Net income | −₩1.60bn | −₩2.99bn | −₩572.6m | ₩676.0m | −₩5.78bn | −₩2.50bn | −₩2.01bn | ₩623.3m | ₩189.6m | ₩291.2m |
| Diluted earnings per share | -4.72 | -8.79 | -1.69 | 1.99 | -17.01 | -7.35 | -5.91 | 1.84 | 0.56 | 0.86 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩72.85bn | ₩66.31bn | ₩70.81bn | ₩70.85bn | ₩72.28bn | ₩74.75bn | ₩75.97bn | ₩77.40bn | ₩76.89bn | ₩62.62bn |
| Total liabilities | ₩46.07bn | ₩43.33bn | ₩44.09bn | ₩42.53bn | ₩46.26bn | ₩46.39bn | ₩51.01bn | ₩49.86bn | ₩50.19bn | ₩35.77bn |
| Debt | ₩1.16bn | ₩4.24bn | ₩4.31bn | ₩5.23bn | ₩6.50bn | ₩9.45bn | ₩34.68bn | ₩34.44bn | ₩34.86bn | ₩26.57bn |
| Shareholders' equity | ₩26.78bn | ₩22.97bn | ₩26.72bn | ₩28.32bn | ₩26.02bn | ₩28.37bn | ₩24.96bn | ₩27.54bn | ₩26.71bn | ₩26.85bn |
| Shares outstanding | 340m | 340m | 340m | 340m | 340m | 340m | 340m | 340m | 340m | 340m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩919.0m | ₩2.59bn | ₩2.02bn | ₩302.9m | ₩1.65bn | ₩6.16bn | ₩4.50bn | ₩5.78bn | ₩3.68bn | ₩1.11bn |
| Capital spending | −₩2.61bn | −₩2.22bn | −₩1.58bn | −₩2.08bn | −₩4.50bn | −₩3.30bn | −₩3.30bn | −₩4.10bn | −₩10.20bn | −₩5.83bn |
| Free cash flow | −₩1.69bn | ₩377.7m | ₩441.6m | −₩1.77bn | −₩2.85bn | ₩2.86bn | ₩1.21bn | ₩1.68bn | −₩6.52bn | −₩4.72bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩16.84bn | ₩15.05bn | ₩16.84bn | ₩17.14bn | ₩18.31bn | ₩16.31bn | ₩15.02bn | ₩13.66bn |
| Gross profit | ₩3.85bn | ₩3.00bn | ₩3.35bn | ₩3.26bn | ₩3.45bn | ₩3.14bn | ₩2.69bn | ₩2.36bn |
| Operating income | ₩345.9m | — | ₩89.7m | ₩7.9m | −₩5.4m | — | −₩928.1m | −₩412.4m |
| Net income | ₩63.3m | −₩484.9m | −₩43.4m | −₩422.2m | −₩332.8m | −₩804.8m | −₩1.08bn | −₩816.0m |
| Diluted earnings per share | 0.19 | -1.43 | -0.13 | -1.24 | -0.98 | -2.37 | -3.18 | -2.40 |
| Cash from operations | −₩4.0m | ₩4.63bn | −₩689.0m | −₩342.0m | ₩75.0m | ₩1.88bn | −₩520.0m | −₩738.0m |
| Capital spending | −₩784.0m | −₩588.0m | −₩359.0m | −₩370.0m | −₩1.72bn | −₩154.0m | −₩870.0m | −₩326.0m |
| Free cash flow | −₩788.0m | ₩4.04bn | −₩1.05bn | −₩712.0m | −₩1.64bn | ₩1.72bn | −₩1.39bn | −₩1.06bn |
| Total assets | ₩73.78bn | ₩74.75bn | ₩72.85bn | ₩69.40bn | ₩68.06bn | ₩68.59bn | ₩66.31bn | ₩68.10bn |
| Debt | ₩2.45bn | ₩2.02bn | ₩1.16bn | ₩2.43bn | ₩1.75bn | ₩1.80bn | ₩4.24bn | ₩4.93bn |
| Shareholders' equity | ₩26.66bn | ₩26.90bn | ₩26.78bn | ₩22.87bn | ₩21.44bn | ₩21.97bn | ₩22.97bn | ₩24.61bn |
Financial ratios
Data as of 15 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 19.2% | 19.1% | 21.0% | 21.4% | 16.0% | 20.9% | — | — | — |
| Operating margin | -0.6% | -2.7% | 1.0% | 3.2% | -8.8% | 1.2% | — | — | — |
| Net margin | -2.3% | -5.1% | -0.9% | 1.1% | -10.4% | -4.1% | — | — | — |
| Return on equity | -6.0% | -13.0% | -2.1% | 2.4% | -22.2% | -8.8% | — | — | — |
| Return on assets | -2.2% | -4.5% | -0.8% | 1.0% | -8.0% | -3.3% | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | 1.9% | 2.3% | — |
| Revenue growth | 17.1% | -9.6% | 0.7% | 16.4% | -10.2% | -0.9% | — | — | — |
| Earnings growth | -46.3% | 421.7% | -184.7% | -111.7% | 131.5% | 24.4% | — | — | — |
| Current ratio | 0.59x | 0.68x | 0.71x | 0.68x | 0.63x | 0.70x | — | — | — |
| Debt to equity | 0.04x | 0.18x | 0.16x | 0.18x | 0.25x | 0.33x | — | — | — |
| Equity ratio | 36.8% | 34.6% | 37.7% | 40.0% | 36.0% | 37.9% | — | — | — |
| Interest coverage | -0.29x | -0.99x | 0.38x | 1.48x | -4.43x | 0.50x | — | — | — |
| R&D as a share of sales | — | — | — | — | — | — | — | 0.9% | 1.0% |
| Buybacks as a share of market value | — | — | — | — | — | — | 0.7% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.2% | 2.2% | 3.2% |
| Net income | — | -8.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 19.2% | 20.2% | 19.7% | 20.2% |
| Operating margin | -1.5% | 0.3% | -0.9% | 0.4% |
| Net margin | -3.6% | -1.8% | -3.4% | -1.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -315.7 | -168.3 | -1138.9 | — | -194.0 | -319.7 | -297.8 | — | — | — |
| Price to sales | 7.4 | 8.6 | 10.1 | 10.6 | 20.3 | 13.0 | 9.6 | 8.5 | 15.4 | 11.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 25-for-1 split · 25 Oct 2017
- 2-for-1 split · 12 Feb 2010
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.